Establish group education sessions: Consider offering group classes for efficiency while providing personalized support for patients starting GLP-1 therapy
Semaglutide GLP-1 works as a GLP-1 receptor agonist to regulate appetite and blood sugar, while tirzepatide combines GIP and GLP-1 receptor agonist actions for enhanced weight loss benefits
Front Hum Neurosci 15:648816 Hermens DF, Hatton SN, Lee RSC et al (2018) In vivo imaging of oxidative stress and fronto-limbic white matter integrity in young adults with mood disorders
You may notice: Nausea, often when starting or increasing the dose A reduced appetite, which supports weight loss Mild stomach discomfort, constipation, or diarrhea Temporary fatigue during early treatment Eating smaller meals, avoiding high-fat foods, and staying hydrated help minimize these effects
LL-37 is the most prominent member of this family in humans
Bookmark this section you'll come back to it